Company news

SI-BONE, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024

March 3, 2024

SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance

February 25, 2024

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024

February 4, 2024

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

January 29, 2024

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023

January 7, 2024

SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023

November 13, 2023

SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance

November 5, 2023

SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023

October 31, 2023

SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023

October 15, 2023

SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods

September 4, 2023

SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023

August 28, 2023

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2023 and Increases Annual Guidance

August 6, 2023

SI-BONE to Present at Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023

July 18, 2023

SI-BONE To Report Second Quarter 2023 Financial Results on August 7, 2023

July 16, 2023

SI-BONE To Present at Jefferies 2023 Healthcare Conference on June 7, 2023

May 23, 2023

SI-BONE Announces Pricing of Public Offering of Common Stock

May 3, 2023

SI-BONE Announces Launch of Public Offering of Common Stock

May 3, 2023

SI-BONE, Inc. Reports Financial Results for the First Quarter 2023 and Increases Annual Guidance

April 30, 2023

SI-BONE to Present at Bank of America Merrill Lynch 2023 Global Healthcare Conference

April 23, 2023

SI-BONE To Report First Quarter 2023 Financial Results on May 1, 2023

April 9, 2023

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Issues 2023 Guidance

February 26, 2023

SI-BONE To Report Fourth Quarter 2022 Financial Results on February 27, 2023

February 5, 2023

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2022

January 8, 2023

SI-BONE to Host a Virtual Fireside Chat at the 25th Annual Needham Growth Conference

January 2, 2023

SI-BONE, Inc. Announces FDA Clearance for Expanded Rod Compatibility with the iFuse Bedrock Granite® Implant System

December 26, 2022

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2022 and Updates Guidance

November 6, 2022

SI-BONE To Report Third Quarter 2022 Financial Results on November 7, 2022

October 16, 2022

SI-BONE To Present at The Morgan Stanley 20th Annual Global Healthcare Conference

August 22, 2022

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2022

August 7, 2022

SI-BONE To Report Second Quarter 2022 Financial Results on August 8, 2022

July 17, 2022

SI-BONE To Present at The Canaccord Genuity 42nd Annual Growth Conference 2022

July 17, 2022

SI-BONE, Inc. Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant System

June 12, 2022

SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse Bedrock Granite, a Breakthrough Pelvic Fixation and Fusion Technology

May 30, 2022

SI-BONE, Inc. Reports First Quarter 2022 Financial Results

May 8, 2022

SI-BONE, Inc. Announces New Technology Add-On Payment for Breakthrough Adult Spinal Deformity Treatment

April 18, 2022

SI-BONE To Report First Quarter 2022 Financial Results on May 9, 2022

April 17, 2022

SI-BONE To Present at BofA Securities 2022 Healthcare Conference

April 17, 2022

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Issues 2022 Revenue Guidance

February 27, 2022

SI-BONE To Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022

January 31, 2022

SI-BONE Announces Revenue for the Fourth Quarter and Full Year 2021

January 9, 2022

SI-BONE to participate in 24th Annual Needham Virtual Growth Conference

December 26, 2021

Mainstay Medical Announces Appointment of Jeffrey Dunn and Eric Major to its Board of Directors

December 13, 2021

SI-BONE, Inc. Announces Updated Exclusive Blue Cross Blue Shield Association Evidence Street Opinion, and New Coverage Policies from Arkansas Blue Cross Blue Shield and Walmart Plans from BlueAdvantage Administrators of Arkansas

December 12, 2021

SI-BONE, Inc. Reports Third Quarter 2021 Financial Results and Updates 2021 Financial Guidance

November 7, 2021

SI-BONE To Report Third Quarter 2021 Financial Results on November 8, 2021

October 17, 2021

SI-BONE, Inc. Announces UnitedHealthcare Adopts Exclusive iFuse Only Coverage for Minimally Invasive SI Joint Fusion

October 10, 2021

SI-BONE to Participate in Upcoming Conferences

August 22, 2021

SI-BONE, Inc. Reports Second Quarter 2021 Financial Results and Announces Exclusive Coverage from Anthem

August 1, 2021

SI-BONE, Inc. Announces Anthem, Inc. Adopts Coverage Guidelines for Sacroiliac Joint Fusion Exclusive to the Triangular iFuse Implant System® for Its More Than 40 Million Members

August 1, 2021

SI-BONE to Present at the Canaccord Genuity 41st Annual Growth Conference

July 28, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 25 calls. Every call is listed under its year.

Decks

The 5 newest of 8 decks. Every deck is listed under its year.